Form 4: Avita Medical Director Suzanne Crowe Acquires Additional Shares
SEC Form 4 Filing
Director Suzanne Crowe purchased 486 shares of Avita Medical, Inc. common stock at $13.15 per share on December 9, 2024.
Summary
- On December 9, 2024, Suzanne Crowe, a director of Avita Medical, Inc., acquired 486 shares of common stock at a price of $13.15 per share.
- The transaction increased Crowe's direct holdings to 36,912 shares, which includes 4,598 shares converted from 22,990 CHESS Depositary Interests (CDIs).
- The reported holdings also include unvested Restricted Stock Units (RSUs).
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a transaction. It doesn't indicate positive or negative outlook for the company.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. It provides transparency into the actions of company directors.
Stakeholder Impact
- The transaction may have a minor impact on shareholder confidence, as it reflects a director's investment in the company.
Key Dates
| Date | Description |
|---|---|
| 12/09/2024 | Date of transaction: Suzanne Crowe purchased 486 shares of Avita Medical, Inc. common stock. |
| 01/29/2025 | Signature date of the report by Nicole Kelsey, by power of attorney. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.